Investors > News Releases
Aug 31, 2018
Myriad Genetics to Present at the 2018 Morgan Stanley Global Healthcare Conference
Corporate
Aug 21, 2018
Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results
Financial
Aug 13, 2018
Myriad Reschedules Release of Fiscal Fourth-Quarter 2018 Financial Results
Corporate
Aug 01, 2018
Myriad to Announce Fiscal Fourth-Quarter 2018 Financial Results on August 14, 2018
Financial
Jul 31, 2018
Myriad Announces Closing of Counsyl Acquisition
Corporate
Jul 25, 2018
Myriad Announces Publication of IMPACT Study in Journal of Psychiatric Research
Products
Jul 18, 2018
Myriad Announces Coverage Decision by Kroger® Prescription Plans for Vectra DA®
Products
Jun 28, 2018
BRACAnalysis® CDx Identifies Patients Who Respond to Lynparza® in SOLO-1 Study
Products
Jun 21, 2018
Top-Five National Payer Issues Positive Coverage Decision for Myriad’s Prolaris® Test for Prostate Cancer
Products
Jun 18, 2018
Myriad’s BRACAnalysis CDx® Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Talazoparib in Metastatic Breast Cancer
Products
Jun 06, 2018
Crescendo Bioscience Announces Four Studies with Vectra® DA Will Be Featured at the 2018 European League Against Rheumatism Annual Meeting
Pipeline
Jun 01, 2018
Myriad Genetics Presents Second Pivotal Validation Study for riskScore™ Test at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Pipeline
May 31, 2018
Myriad Genetics to Present at Two Upcoming Investor Conferences
Corporate
May 31, 2018
GeneSight® Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Setting
Products
May 28, 2018
Myriad Genetics Signs Definitive Agreement to Acquire Counsyl, Inc.
Corporate